In Western Europe (EU-16) countries major portion of healthcare is borne by the government.
These Western Europe (EU-16) countries spend 9 to 11% of their GDP on the healthcare of its
citizens. So the recent Euro zone crisis has hardly hit the In Vitro Diagnostics (IVD) market for
the year 2011 and 2012. But from 2013 the growth for In Vitro Diagnostics (IVD) industry is
expected to be back on track. Western Europe (EU-16) In Vitro Diagnostics (IVD) market is one
of the biggest markets globally. Western Europe (EU-16) In Vitro Diagnostics (IVD) market is
expected to be more than Euro 11 Billion by 2015.
Germany, France and Italy are three biggest markets in Western European (EU-16) countries.
Germany controls the biggest market share closely followed by France and Italy in 2011.
Together these three countries controls 58.5% market share for the year 2011. From our
research we found that only two countries out of 16 countries studied in this report is expected
to show a contraction in In Vitro Diagnostics (IVD) market for the year 2012. Whereas rest of
the Western Europe (EU-16) countries will either grow marginal or will show no growth for the
year 2012. However from 2013 every country is expected to back on track and expected to
Renub Research report entitled “Western Europe (EU-16) In Vitro Diagnostics Market Report
& Forecast (2012 – 2015)” provides a comprehensive assessment of the 16 Western European
countries In Vitro Diagnostics (IVD) market scenario and its forecast. The report also provides
market landscape and market share information in the Western Europe (EU-16) IVD market.
The report also entails major drivers and challenges of Western Europe (EU-16) In Vitro
Countries Analyzed in this Report
Germany, France, Italy, United Kingdom, Spain, Netherlands, Greece, Portugal, Belgium,
Sweden, Austria, Denmark, Finland, Ireland, Switzerland, Norway